RSS

Steph Hazlegreaves

CPhI Worldwide has released the findings from its debate on the global growth in finished dosage forms, ahead of the launch of a new co-located event at CPhI Worldwide on October 4th and 6th. more

News

Laboratoris Sanifit has appointed Dr Preston S. Klassen, MD, MHS as its chief medical officer and announced the launch of its US Subsidiary, based in San Diego, USA. more

News

Colorcon and BASF have signed an agreement for the supply of pharmaceutical film coatings. more

News

The Biomax Symposium on “Bringing Big and Complex Data into Clinical Practice” will take place on June 24th 2016 at the Innovations- und Gründerzentrum Biotechnologie (IZB) in Martinsried, Germany. more

News

Thermo Fisher Scientific has announced plans to extend its technology collaboration with the University of Birmingham’s new Phenome Centre. more

News

IBM Researchand Singapore's Institute of Bioengineering and Nanotechnology (IBN) have announced that they have identified a new breakthrough macromolecule that could help prevent deadly virus infections. more

News

The August Faller Group, pharmaceutical and healthcare packaging solution provider, has reported a turnover of €123.4 million (£955.7 million, $138.3 million) in 2015, ahead of plans to digitalise its business. more

News

Scientists have identified a chemical compound that is highly effective at blocking the growth of breast cancer cells. more

News

Virologists from KU Leuven, Belgium, have shown that an experimental antiviral drug against hepatitis C slows down the development of Zika in mice. more

News

A patient in Manchester is the first to take part in a pioneering cancer trial. more

News

Contract manufacturing group Vetter has been awarded with the Triumph award by AbbVie, a major biopharmaceutical company. more

News

Hermes Pharma has announced that its facility in Wolfratshausen, Germany now meets the requirements to produce and package organic food substances. more

News

Bayer and Biontech, a immunotherapy company headquartered in Mainz have entered into an agreement to develop novel, first-in-class mRNA vaccines and therapeutics specifically for animal health applications. more

News